[SERBADK] QoQ TTM Result on 30-Jun-2018 [#2]

Stock
[SERBADK] SERBA DINAMIK HOLDINGS BERHAD
Announcement Date
29-Aug-2018
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2018
Quarter
30-Jun-2018 [#2]
Profit Trend
QoQ- 6.04%
YoY- 12.26%
Quarter Report
Latest QR
Upcoming QR
SERBADK's Result
SERBADK's Financial Summary
View:
Show?
TTM Result
31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 CAGR
Revenue 3,536,736 3,283,174 3,102,548 2,985,649 2,831,224 2,712,822 2,647,219 21.32%
PBT 462,018 434,051 408,668 397,349 376,496 361,188 359,236 18.28%
Tax -53,105 -44,783 -50,413 -54,496 -54,574 -54,675 -35,321 31.27%
NP 408,913 389,268 358,255 342,853 321,922 306,513 323,915 16.82%
-
NP to SH 407,406 387,903 359,119 343,922 324,343 310,024 329,739 15.15%
-
Tax Rate 11.49% 10.32% 12.34% 13.71% 14.50% 15.14% 9.83% -
Total Cost 3,127,823 2,893,906 2,744,293 2,642,796 2,509,302 2,406,309 2,323,304 21.94%
-
Net Worth 2,158,695 2,099,954 2,011,845 1,953,105 1,780,000 1,388,399 1,361,699 35.99%
Dividend
31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 CAGR
Div 123,353 116,634 104,218 100,013 88,465 88,192 66,832 50.52%
Div Payout % 30.28% 30.07% 29.02% 29.08% 27.28% 28.45% 20.27% -
Equity
31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 CAGR
Net Worth 2,158,695 2,099,954 2,011,845 1,953,105 1,780,000 1,388,399 1,361,699 35.99%
NOSH 1,468,500 1,468,500 1,468,500 1,468,500 1,468,500 1,335,000 1,335,000 6.56%
Ratio Analysis
31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 CAGR
NP Margin 11.56% 11.86% 11.55% 11.48% 11.37% 11.30% 12.24% -
ROE 18.87% 18.47% 17.85% 17.61% 18.22% 22.33% 24.22% -
Per Share
31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 CAGR
RPS 240.84 223.57 211.27 203.31 198.82 203.21 198.29 13.85%
EPS 27.74 26.41 24.45 23.42 22.78 23.22 24.70 8.05%
DPS 8.40 7.94 7.10 6.81 6.21 6.61 5.01 41.17%
NAPS 1.47 1.43 1.37 1.33 1.25 1.04 1.02 27.61%
Adjusted Per Share Value based on latest NOSH - 1,468,500
31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 CAGR
RPS 94.89 88.09 83.24 80.10 75.96 72.78 71.02 21.33%
EPS 10.93 10.41 9.64 9.23 8.70 8.32 8.85 15.12%
DPS 3.31 3.13 2.80 2.68 2.37 2.37 1.79 50.71%
NAPS 0.5792 0.5634 0.5398 0.524 0.4776 0.3725 0.3653 36.01%
Price Multiplier on Financial Quarter End Date
31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 CAGR
Date 29/03/19 31/12/18 28/09/18 29/06/18 30/03/18 29/12/17 29/09/17 -
Price 3.77 3.78 3.81 3.25 3.42 3.24 2.32 -
P/RPS 1.57 1.69 1.80 1.60 1.72 1.59 1.17 21.68%
P/EPS 13.59 14.31 15.58 13.88 15.02 13.95 9.39 27.97%
EY 7.36 6.99 6.42 7.21 6.66 7.17 10.65 -21.85%
DY 2.23 2.10 1.86 2.10 1.82 2.04 2.16 2.15%
P/NAPS 2.56 2.64 2.78 2.44 2.74 3.12 2.27 8.35%
Price Multiplier on Announcement Date
31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 CAGR
Date 29/05/19 27/02/19 27/11/18 29/08/18 22/05/18 26/02/18 21/11/17 -
Price 4.06 3.96 3.85 3.79 3.31 3.55 2.63 -
P/RPS 1.69 1.77 1.82 1.86 1.66 1.75 1.33 17.33%
P/EPS 14.63 14.99 15.74 16.18 14.53 15.29 10.65 23.59%
EY 6.83 6.67 6.35 6.18 6.88 6.54 9.39 -19.13%
DY 2.07 2.01 1.84 1.80 1.88 1.86 1.90 5.88%
P/NAPS 2.76 2.77 2.81 2.85 2.65 3.41 2.58 4.60%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment